These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33179309)

  • 21. Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen.
    Takahashi T; Higashi S; Nishiyama H; Segawa T; Nakamura E; Kinoshita H; Itoh N; Yamamoto S; Kamoto T; Habuchi T; Ogawa O
    Jpn J Clin Oncol; 2006 Feb; 36(2):104-8. PubMed ID: 16418182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases.
    Odenike OM; Sobecks RM; Janisch L; Huo D; Zimmerman TM; Daugherty CK; Ratain MJ; Larson RA
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):553-61. PubMed ID: 15349753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
    Niho S; Kubota K; Goto K; Ohmatsu H; Matsumoto T; Kakinuma R; Nishiwaki Y
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):19-24. PubMed ID: 12712259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer.
    Maurel J; Martin-Richard M; Conill C; Sánchez M; Petriz L; Ginès A; Miquel R; Gallego R; Cajal R; Ayuso C; Navarro S; Marmol M; Nadal C; Augé JM; Fernández-Cruz L; Gascón P
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1391-8. PubMed ID: 16965868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy.
    Kanai M; Matsumoto S; Nishimura T; Matsumura Y; Hatano E; Mori A; Masui T; Kawaguchi Y; Nakamura E; Tada S; Kitano T; Ishiguro H; Yanagihara K; Chiba T
    Ann Oncol; 2010 Jan; 21(1):189-90. PubMed ID: 19889615
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer.
    Robert F; Blumenschein G; Herbst RS; Fossella FV; Tseng J; Saleh MN; Needle M
    J Clin Oncol; 2005 Dec; 23(36):9089-96. PubMed ID: 16301597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gemcitabine induced skin rash.
    Dua V; Goyal H
    Indian Pediatr; 2013 Apr; 50(4):430. PubMed ID: 23665611
    [No Abstract]   [Full Text] [Related]  

  • 28. A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer.
    Dent SF; Gertler S; Verma S; Segal R; Young V; Goel R; Keller O; Canil C; Iscoe N
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):557-61. PubMed ID: 19593565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer.
    Starling N; Watkins D; Cunningham D; Thomas J; Webb J; Brown G; Thomas K; Oates J; Chau I
    J Clin Oncol; 2009 Nov; 27(33):5499-505. PubMed ID: 19858399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I trial using weekly administration of gemcitabine and docetaxel in patients with advanced pancreatic carcinoma.
    Meyer F; Lueck A; Hribaschek A; Lippert H; Ridwelski K
    Chemotherapy; 2004 Dec; 50(6):289-96. PubMed ID: 15608445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Burris HA; Billings FT; Bradof JE; Baker M; Greco FA
    Cancer; 2001 Nov; 92(9):2391-8. PubMed ID: 11745295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study.
    Petrioli R; Roviello G; Fiaschi AI; Laera L; Marrelli D; Roviello F; Francini E
    Cancer Chemother Pharmacol; 2015 Apr; 75(4):683-90. PubMed ID: 25618415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
    Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: a phase 2 study.
    Rubovszky G; Láng I; Ganofszky E; Horváth Z; Juhos E; Nagy T; Szabó E; Szentirmay Z; Budai B; Hitre E
    Eur J Cancer; 2013 Dec; 49(18):3806-12. PubMed ID: 24007821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie'.
    Boeck S; Vehling-Kaiser U; Waldschmidt D; Kettner E; Märten A; Winkelmann C; Klein S; Kojouharoff G; Gauler T; Fischer von Weikersthal L; Clemens MR; Geissler M; Greten TF; Hegewisch-Becker S; Neugebauer S; Heinemann V
    Anticancer Drugs; 2010 Jan; 21(1):94-100. PubMed ID: 19770635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.
    Shepherd FA; Cormier Y; Burkes R; Evans WK; Goss G; Klimo P; Feld R; Taylor M
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-27-S8-30. PubMed ID: 9207313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gemcitabine combined with docetaxel for the treatment of unresectable pancreatic carcinoma.
    Jacobs AD; Otero H; Picozzi VJ; Aboulafia DM
    Cancer Invest; 2004; 22(4):505-14. PubMed ID: 15565807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the 'Arbeitsgemeinschaft Internistische Onkologie'.
    Haas M; Siveke JT; Schenk M; Lerch MM; Caca K; Freiberg-Richter J; Fischer von Weikersthal L; Kullmann F; Reinacher-Schick A; Fuchs M; Kanzler S; Kunzmann V; Ettrich TJ; Kruger S; Westphalen CB; Held S; Heinemann V; Boeck S
    Eur J Cancer; 2018 May; 94():95-103. PubMed ID: 29549862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combination chemotherapy with gemcitabine and S-1 for advanced pancreatic cancer].
    Nakamura K; Yamaguchi T; Sudo K; Ishihara T; Saisho H
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():219-23. PubMed ID: 16898006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial.
    Gatzemeier U; Pluzanska A; Szczesna A; Kaukel E; Roubec J; De Rosa F; Milanowski J; Karnicka-Mlodkowski H; Pesek M; Serwatowski P; Ramlau R; Janaskova T; Vansteenkiste J; Strausz J; Manikhas GM; Von Pawel J
    J Clin Oncol; 2007 Apr; 25(12):1545-52. PubMed ID: 17442998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.